Clinical trials: CAH - Congenital Adrenal Hyperplasia, open to volunteers
- Condition CAH - Congenital Adrenal Hyperplasia
- Status Open to volunteers
- Funder type Industry (pharma, biotech, devices)
Congenital Adrenal Hyperplasia (CAH)
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of OMS1620
The goal of this study is to explore the safety, drug concentrations and effects on adrenal gland hormones after a single dose or multiple doses of OMS1620 in healthy participants.
- Trial name
- NCT07811089
- Testing
- OMS1620
- Volunteers
- 84 people, healthy volunteers welcome
- Sponsor
- OMass Therapeutics Australia Proprietary Ltd